• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Device Problem Complete Blockage (1094)
Patient Problem Occlusion (1984)
Event Date 12/29/2018
Event Type  Injury  
Manufacturer Narrative
Since no patient id is available, the gore event number was used as the patient identifier.The patient age and patient gender reflects the mean age and gender stated in the article.The date of online publication was used as the event date.Lot/serial numbers were not provided, therefore, a review of the manufacturing records could not be conducted.
 
Event Description
The following publication was reviewed: ¿long-term follow-up after stent graft placement for access-site and access-related vascular injury during tavi ¿ the bonn-copenhagen experience¿(alexander sedaghat et al., international journal of cardiology 281, published online 29-dec-2018).The article analyzed the outcome of 71 patients who had undergone transcatheter aortic valve implantation (tavi) between march 2010 and october 2015 with implantation of a gore viabahn® endoprosthesis (30/71) or fluency stent graft (40/71) to treat access-site or access-related vascular injury (asarvi).Implantations were mostly due to access-site bleeding complications (83.1%) in the common femoral artery (97.1%).Follow-up was performed with duplex sonography in all patients after a median of 3.9 years after tavi.The article includes the following case: a surgical intervention was necessary due to complete obstruction of the profunda femoral artery.No additional info in regards to the case was provided in the article.
 
Manufacturer Narrative
G5: corrected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9108730
MDR Text Key161511775
Report Number2017233-2019-00889
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P130006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 09/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/24/2019
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received10/22/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age82 YR
-
-